Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

FDA gives orphan drug designation for Ga-68 DOTATOC

Gallium-68 DOTATOC is now blazing faster trail toward U.S. regulatory approval for neuroendocrine cancer imaging, according to a Nov. 18 statement from the Society of Nuclear Medicine and Molecular Imaging (SNMMI). 

Four times longer half-life with Sc-44 DOTA oncologic PET agent

A longer lasting alternative to gadolinium-68 for PET cancer imaging prior to radionuclide therapy has been found in a cyclotron-produced scandium-44 agent, according to a study published online Nov. 6 in the Journal of Nuclear Medicine.

Prebiopsy counseling could improve quality of life

Younger patients experience poorer short-term quality of life in relation to percutaneous breast biopsy procedures, therefore potentially warranting individualized prebiopsy counseling, according to a study published online Nov. 19 in Radiology.

Thumbnail

Comorbidity-adjusted life expectancy optimizes screening recommendations

Calculating comorbidity-adjusted life expectancy could help physicians determine whether to continue or cease cancer screening in elderly patients, according to a study published Nov. 18 in Annals of Internal Medicine.

Quantum dots facilitate a leap into alternative energy

The semiconductor photocatalysts known in molecular imaging as "quantum dots" are now being used for something completely different: alternative energy. The nanocrystals, instead of highlighting tissues, are harnessing methanol through a process of photosynthesis. This and other research, including advances in biomedical 3D printing and oncologic iron-based MRI contrast agents are featured in a profile of new research published in the New York Academy of Sciences magazine.

Thumbnail

Gamma Medica Debuts Enhancements to LumaGEM Molecular Breast Imaging System at RSNA 2013

Gamma Medica, Inc. debuts a range of enhancements to its LumaGEM molecular breast imaging (MBI) system at the Radiological Society of North America (RSNA) 2013 conference, as the company expands sales and marketing efforts for its groundbreaking breast imaging technology.

Thumbnail

A Faster, Smaller and Versatile CT Solution from Toshiba

Healthcare providers searching for a CT system that offers the best in usability, dose management and scalability now have a solution with Toshiba’s all-new AquilionTM PRIME. The system delivers on customers’ clinical and financial needs today, with the ability to adapt as those needs change in the future.

USPSTF begins updating breast cancer screening recommendations

The U.S. Preventive Services Task Force (USPSTF) has begun updating its recommendations on screening for breast cancer, according to its website .

Displaying 5273 - 5280 of 23549

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.